Insiders · Profile

King-Jones Heidy

See Remarks at Spyre Therapeutics. Filing since 1 Sep 2026. CIK 0001794898

Company

Date

Role

Action

Shares

Amount

Of holding

SYRE Spyre Therapeutics, Inc.

1 Oct 2026

See Remarks

Sold on a plan

28,933

$2.63M

91.0%

SYRE Spyre Therapeutics, Inc.

2 Sep 2026

See Remarks

Sold on a plan

400

$36.00K

12.3%

SYRE Spyre Therapeutics, Inc.

1 Sep 2026

See Remarks

Sold on a plan

27,999

$2.44M

90.8%

3 decisions on file.